These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19840322)

  • 1. Propranolol treatment for hemangioma of infancy: risks and recommendations.
    Lawley LP; Siegfried E; Todd JL
    Pediatr Dermatol; 2009; 26(5):610-4. PubMed ID: 19840322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol for infantile haemangiomas: a review.
    Starkey E; Shahidullah H
    Arch Dis Child; 2011 Sep; 96(9):890-3. PubMed ID: 21622997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: a case report.
    Breur JM; de Graaf M; Breugem CC; Pasmans SG
    Pediatr Dermatol; 2011; 28(2):169-71. PubMed ID: 20738795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualized dosing of oral propranolol for treatment of infantile hemangioma: a prospective study.
    Prasad A; Sinha AK; Kumar B; Prasad A; Kumari M
    Pan Afr Med J; 2019; 32():155. PubMed ID: 31303926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol induced hypoglycemia.
    Horev A; Haim A; Zvulunov A
    Pediatr Endocrinol Rev; 2015 Mar; 12(3):308-10. PubMed ID: 25962208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol treatment for hemangioma of infancy.
    Bonini FK; Bellodi FS; Souza EM
    An Bras Dermatol; 2011; 86(4):763-6. PubMed ID: 21987146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the Safety of Oral Propranolol Therapy in Patients With PHACE Syndrome.
    Olsen GM; Hansen LM; Stefanko NS; Mathes E; Puttgen KB; Tollefson MM; Lauren C; Mancini AJ; McCuaig CC; Frieden IJ; Adams D; Baselga E; Chamlin S; Gupta D; Frommelt P; Garzon MC; Horii K; Klajn J; Maheshwari M; Newell B; Nguyen HL; Nopper A; Powell J; Siegel DH; Drolet BA
    JAMA Dermatol; 2020 Feb; 156(2):186-190. PubMed ID: 31825455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep coma in a child treated with propranolol for infantile hemangioma.
    Bakalli I; Kola E; Lluka R; Celaj E; Sala D; Gjeta I; Sallabanda S; Klironomi D
    BMC Pediatr; 2019 Jul; 19(1):216. PubMed ID: 31266444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, controlled trial of oral propranolol in infantile hemangioma.
    Léauté-Labrèze C; Hoeger P; Mazereeuw-Hautier J; Guibaud L; Baselga E; Posiunas G; Phillips RJ; Caceres H; Lopez Gutierrez JC; Ballona R; Friedlander SF; Powell J; Perek D; Metz B; Barbarot S; Maruani A; Szalai ZZ; Krol A; Boccara O; Foelster-Holst R; Febrer Bosch MI; Su J; Buckova H; Torrelo A; Cambazard F; Grantzow R; Wargon O; Wyrzykowski D; Roessler J; Bernabeu-Wittel J; Valencia AM; Przewratil P; Glick S; Pope E; Birchall N; Benjamin L; Mancini AJ; Vabres P; Souteyrand P; Frieden IJ; Berul CI; Mehta CR; Prey S; Boralevi F; Morgan CC; Heritier S; Delarue A; Voisard JJ
    N Engl J Med; 2015 Feb; 372(8):735-46. PubMed ID: 25693013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma.
    Holland KE; Frieden IJ; Frommelt PC; Mancini AJ; Wyatt D; Drolet BA
    Arch Dermatol; 2010 Jul; 146(7):775-8. PubMed ID: 20644039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No Increased Risks Associated with Propranolol Treatment for Infantile Hemangioma in Preterm Infants were Identified at 3 Years of Age.
    Li L; Wei L; Xu ZG; Ma L
    Am J Clin Dermatol; 2019 Apr; 20(2):289-293. PubMed ID: 30618026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral propranolol for infantile haemangioma may be associated with transient gross motor delay.
    Mahon C; Heron G; Perkins D; Drage A; Wargon O
    Br J Dermatol; 2018 Jun; 178(6):1443-1444. PubMed ID: 29330846
    [No Abstract]   [Full Text] [Related]  

  • 13. Allergic contact dermatitis caused by topical propranolol in a 5-month-old baby.
    Bonifazi E; Milano A; Foti C
    Contact Dermatitis; 2014 Oct; 71(4):250-1. PubMed ID: 25231389
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemangioma can be effectively treated with propranolol. Experiences from twelve cases, with promising results and few side effects].
    Rosenkvist CJ; Brudin L; Jörgensen E
    Lakartidningen; 2013 May 7-21; 110(19-20):942-5. PubMed ID: 23745499
    [No Abstract]   [Full Text] [Related]  

  • 15. β-blockers for infantile hemangiomas: a single-institution experience.
    Blatt J; Morrell DS; Buck S; Zdanski C; Gold S; Stavas J; Powell C; Burkhart CN
    Clin Pediatr (Phila); 2011 Aug; 50(8):757-63. PubMed ID: 21525081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts in the management of periocular infantile (capillary) hemangioma.
    Ni N; Guo S; Langer P
    Curr Opin Ophthalmol; 2011 Sep; 22(5):419-25. PubMed ID: 21730838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions.
    Hermans DJ; Bauland CG; Zweegers J; van Beynum IM; van der Vleuten CJ
    Br J Dermatol; 2013 Apr; 168(4):837-43. PubMed ID: 23278381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More on propranolol for hemangiomas of infancy.
    Siegfried EC; Keenan WJ; Al-Jureidini S
    N Engl J Med; 2008 Dec; 359(26):2846; author reply 2846-7. PubMed ID: 19109584
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemangiomas of the nasal tip treated with propranolol.
    Ben-Amitai D; Halachmi S; Zvulunov A; Raveh E; Kalish E; Lapidoth M
    Dermatology; 2012; 225(4):371-5. PubMed ID: 23428617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of infantile hemangiomas with beta-blockers: a review.
    Shah S; Frieden IJ
    Skin Therapy Lett; 2013; 18(6):5-7. PubMed ID: 24305730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.